Submitted by elizabethwu1 on Thu, 02/14/2019 - 12:31pm NCT03131453 Umibecestat United States Thursday, August 3, 2017 – Monday, March 31, 2025 2 000 Phase 2/3 Alzheimer's Disease Thursday, February 14, 2019 Novartis Pharmaceuticals Corporation Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by elizabethwu1 on
Submitted by elizabethwu1 on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.